PULsecath mechanicaL Support Evaluation

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Coronary Artery DiseaseHeart FailureCardiogenic Shock
Interventions
DEVICE

iVAC2L pVAD

To determine the effects of the new PFLVAD PulseCath® iVAC2L on ventricular loading using left ventricular pressure-volume loops, in association with systemic and pulmonary hemodynamic parameters obtained from right and left catheterization. Additionally, assessments of specific load and flow-dependent humoral factors, and cardiac enzymes, will be made during and after the use of mechanical circulatory support.

Trial Locations (3)

Unknown

Clinic Pasteur, Toulouse

Kings College London, St. Thomas' Hospital, London

3015CE

Erasmus Medical Center, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER